10:07 AM EST - Fennec Pharmaceuticals Inc. : Announced it has repurchased and redeemed all of Fennec’s outstanding convertible notes issued to Petrichor Opportunities Fund I LP and Petrichor Opportunities Fund I Intermediate LP using proceeds from the closing of the Company’s previously announced underwritten public offering in the United States and concurrent private placement in Canada, closed on November 17 and 18, respectively. The Company has no outstanding debt after the redemption of Petrichor’s convertible notes. Fennec Pharmaceuticals Inc.
shares T.FRX are trading down $0.01 at $12.17.
